Improvement in NAFLD after liraglutide administration has been suggested to be associated with the effects of liraglutide on insulin sensitivity and its anti-inflammatory action [28,29,30]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.